MRSI for glioma treatment planning and evaluation
Gliomas account for over half of primary brain tumors in adults, most of which
are high grade with median survival times of 6-24 months. Target delineation
is difficult because of spatial heterogeneity, complicated infiltration
patterns, and poorly defined margins on conventional MR and CT images. Within
a tumor may also be areas with markedly different biologic and metabolic
characteristics. Current treatment planning ignores biologic information about
extent and degree of malignancy of tumor. Specialized techniques such as
magnetic resonance spectroscopic imaging (MRSI) and diffusion tensor imaging
(DTI) can provide information about tumor activity and infiltration based upon
the levels of cellular metabolites and tumor microstructure. Our
collaboration with
Emory Radiation Oncology is creating software that will
incorporate findings from these methods to better guide dose prescription and
to evaluate tumor response. Statistical techniques evaluating biologic and
metabolic characteristics before and after tumor treatment are being developed
to quantitatively describe tumor progression.
Collaborators: Tim Fox, Ian Crocker, Hui-Kuo Shu (Radiation Oncology)
____________________________________________